上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2025 , Vol. 45 >Issue 5: 653 - 660

DOI: https://doi.org/10.3969/j.issn.1674-8115.2025.05.015

短篇论著

原发口腔外周T细胞淋巴瘤非特指型的特点分析

  • 黄润语 ,
  • 张春叶 ,
  • 张颖 ,
  • 赵峥岩 ,
  • 杨扬 ,
  • 吴岚
展开
  • 1.上海交通大学医学院附属第九人民医院口腔黏膜病科，上海交通大学口腔医学院，国家口腔医学中心，国家口腔疾病临床医学研究中心，上海市口腔医学重点实验室，上海市口腔医学研究所，上海 200011
    2.上海交通大学医学院附属第九人民医院口腔病理科，上海交通大学口腔医学院，国家口腔医学中心，国家口腔疾病临床医学研究中心，上海市口腔医学重点实验室，上海市口腔医学研究所，上海 200011
    3.徐州医科大学附属口腔医院牙周黏膜病科，徐州 221002
黄润语（1999—），女，住院医师，硕士生；电子信箱：shdiver@outlook.com。
吴　岚，主任医师，博士；电子信箱：teana_wu@sina.com。

收稿日期: 2024-11-07

  录用日期: 2025-02-24

  网络出版日期: 2025-05-28

基金资助

上海市科学技术委员会基金(21S21902000);上海市卫生健康委员会项目［（ZY（2021-2023）-0207-01-04,2022CX009）］;上海交通大学医学院附属第九人民医院交叉基金(JYJC202111)

收起

Features of oral peripheral T-cell lymphoma, not otherwise specified

  • HUANG Runyu ,
  • ZHANG Chunye ,
  • ZHANG Ying ,
  • ZHAO Zhengyan ,
  • YANG Yang ,
  • WU Lan
Expand
  • 1.Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology, Shanghai 200011, China
    2.Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology, Shanghai 200011, China
    3.Department of Periodontal and Mucosal Diseases, Affiliated Stomatological Hospital of Xuzhou Medical University, Xuzhou 221002, China.
WU Lan, E-mail: teana_wu@sina.com.

Received date: 2024-11-07

  Accepted date: 2025-02-24

  Online published: 2025-05-28

Supported by

Shanghai Municipal Commission of Science and Technology Fund(21S21902000);Shanghai Municipal Commission of Health Fund [(ZY(2021-2023)- 0207-01-04, 2022CX009)];Cross Project Cooperation Fund of Shanghai Ninth People′s Hospital, Shanghai Jiao Tong University School of Medicine(JYJC202111)

Fold

摘要

目的·探讨原发于口腔的外周T细胞淋巴瘤-非特指型（peripheral T-cell lymphoma， not otherwise specified，PTCL-NOS）的临床表现和免疫表型特征。方法·回顾性分析2020年8月至2024年8月就诊于上海交通大学医学院附属第九人民医院口腔黏膜病科、口腔为首发部位、确诊为PTCL-NOS的患者的病史和病理资料，并检索PubMed、Web of Science、Embase、Scopus和中国知网共5个数据库，结合2014年1月至2024年9月国际上相关病例报道，对临床特点、病理学特点进行分析归纳。结果·共20例口腔PTCL-NOS病例纳入研究。其中男性11例（55.0%），女性9例（45.0%）；患者首诊年龄25~77岁，平均（52.53±12.94）岁；好发部位为舌部（25.0%）、腭部（25.0%）及颊部（20.0%）；19例（95.0%）不伴B症状。纳入病例免疫表型阳性表达情况为CD3（19/19）、CD4（11/13）、CD8（7/12）、CD2（5/6）、CD7（5/5）、TIA-1（6/7）、GB（9/13）、perforin（4/6），EBER均阴性表达（8/8）。85%的病例Ki-67增殖指数≥60%。结论·口腔PTCL-NOS极为罕见，临床进展极具侵袭性，口腔表现为深而大的黏膜溃疡，基底高低不平，可扪及结节。病理特征具有异质性，免疫表型检测有助于早期诊断和分型。口腔科医师需加深对该疾病的认识，以避免错过此类恶性疾病的早期诊断与治疗。

关键词： 口腔特征; 外周T细胞淋巴瘤; 非特指型; 临床病理

本文引用格式

黄润语 , 张春叶 , 张颖 , 赵峥岩 , 杨扬 , 吴岚 . 原发口腔外周T细胞淋巴瘤非特指型的特点分析[J]. 上海交通大学学报（医学版）, 2025 , 45(5) : 653 -660 . DOI: 10.3969/j.issn.1674-8115.2025.05.015

Abstract

Objective ·To investigate the clinical manifestations and immunophenotypic features of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), involving the oral cavity. Methods ·The medical histories and pathology records of patients diagnosed with oral PTCL-NOS in the Department of Oral Mucosal Diseases of Shanghai Ninth People′s Hospital, Shanghai Jiao Tong University School of Medicine, between August 2020 and August 2024 were retrospectively analyzed. In addition, 5 databases, including PubMed, Web of Science, Embase, Scopus, and CNKI, were searched, and relevant cases reported internationally from January 2014 to September 2024 were reviewed. Results ·A total of 20 oral PTCL-NOS cases were included, comprising 11 males (55.0%) and 9 females (45.0%). The patients′ ages at initial diagnosis ranged from 25 to 77 years, with a mean age of (52.53±12.94) years. The most common sites were the tongue (25.0%), palate (25.0%), and buccal mucosa (20.0%). Nineteen cases (95.0%) had no B symptoms. The cases were positive for CD3 (19/19), CD4 (11/13), CD8 (7/12), CD2 (5/6), CD7 (5/5), TIA-1 (6/7), GB (9/13), perforin (4/6). EBER expression was negative (8/8). The Ki-67 proliferation index was ≥60% in 85% of cases. Conclusions ·Oral PTCL-NOS is extremely rare and has an aggressive clinical behavior. The oral manifestation presents as deep and large mucosal ulcers with uneven bases, and nodules can be palpable. The pathological features are heterogeneous. Immunophenotype detection is useful for early diagnosis and classification. It is essential for stomatologists to enhance their awareness of this malignancy to avoid delayed diagnosis and treatment.

Key words： oral feature; peripheral T-cell lymphoma (PTCL); not otherwise specified (NOS); clinical pathology

参考文献

1 SWERDLOW S H, CAMPO E, HARRIS N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Revised 4th ed. Lyon: IARC Press, 2017.
2 LEE J H, LEE S H. A poor prognostic case of peripheral T-cell lymphoma in the base of tongue with chemotherapy followed by radiation therapy[J]. Springerplus, 2014, 3: 731.
3 NARLA S, ANNAPURNESWARI S, PARAMESWARAN A, et al. Peripheral T-cell lymphoma of tongue: report of a rare case and review of literature[J]. J Oral Maxillofac Pathol, 2016, 20(2): 332.
4 薛敏, 高冶, 段介君. 以舌部肿物为表现的外周型T细胞淋巴瘤1例[J]. 宁夏医科大学学报, 2017, 39(1): 115-116.
  XUE M, GAO Y, DUAN J J. A case of peripheral T-cell lymphoma presenting as a tongue mass[J]. Journal of Ningxia Medical University, 2017, 39(1): 115-116.
5 DOS SANTOS H L R, ALVES C G B, ALMENDRA MATTOS R M, et al. Peripheral T-cell non-Hodgkin lymphoma manifesting as a primary lesion on the lip: a rare case report[J]. Spec Care Dentist, 2018, 38(6): 438-444.
6 REN X Y, CHENG Y, WU S F, et al. Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status[J]. Diagn Pathol, 2020, 15(1): 30.
7 ALMEIDA DE ARRUDA J A, DE CASTRO ABRANTES T, CUNHA J L S, et al. Mature T/NK-cell lymphomas of the oral and maxillofacial region: a multi-institutional collaborative study[J]. J Oral Pathol Med, 2021, 50(6): 548-557.
8 ASADI A A, MAHMOUDI H, MOFIDI A, et al. Peripheral T-cell lymphoma of the oral cavity: a case report[J]. Cancer Rep (Hoboken), 2023, 6(1): e1751.
9 DE OLIVEIRA E M, DE CáCERES C V B L, FERNANDES-RODRIGUES C I, et al. Oral manifestations of peripheral T cell lymphoma, not otherwise specified: case series and review of the current literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2025, 139(2): e37-e45.
10 PILERI S A, TABANELLI V, FIORI S, et al. Peripheral T-cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment[J]. Cancers (Basel), 2021, 13(18): 4535.
11 COSTELLO R, SANCHEZ C, LE TREUT T, et al. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations[J]. Br J Haematol, 2010, 150(1): 21-27.
12 LUO J J, CRAVER A, BAHL K, et al. Etiology of non-Hodgkin lymphoma: a review from epidemiologic studies[J]. J Natl Cancer Cent, 2022, 2(4): 226-234.
13 COCCO P, VERMEULEN R, FLORE V, et al. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph analysis[J]. Occup Environ Med, 2013, 70(11): 795-802.
14 BASSIG B A, SHU X O, FRIESEN M C, et al. Occupational exposure to benzene and risk of non-Hodgkin lymphoma in an extended follow-up of two population-based prospective cohorts of Chinese men and women[J]. Int J Cancer, 2024, 155(12): 2159-2168.
15 BRYER E, HENRY D. Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature[J]. Int J Hematol Oncol, 2018, 7(1): IJH03.
16 SCHMITZ N, DE LEVAL L. How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future[J]. Br J Haematol, 2017, 176(6): 851-866.
17 WENT P, AGOSTINELLI C, GALLAMINI A, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score[J]. J Clin Oncol, 2006, 24(16): 2472-2479.
18 LIM S T, HEE S W, QUEK R, et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis[J]. Eur J Haematol, 2008, 80(1): 55-60.
19 D′AMORE F, GAULARD P, TRüMPER L, et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2015, 26(Suppl 5): v108-v115.
20 SHEN Q D, WANG L, ZHU H Y, et al. Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma[J]. J Cancer, 2021, 12(1): 163-169.
21 MINA A, PRO B. T time: emerging and new therapies for peripheral T-cell lymphoma[J]. Blood Rev, 2022, 52: 100889.
22 李静, 李志铭. 外周T细胞淋巴瘤和结外NK/T细胞淋巴瘤研究进展[J]. 肿瘤药学, 2024, 14(1): 16-21.
  LI J, LI Z M. Research progress of peripheral T-cell lymphoma and extranodal NK/T-cell lymphoma [J]. Anti-tumor Pharmacy, 2024, 14(1): 16-21.
Options
文章导航

/

〈 〉